CBT Straddle Strategy
CBT (Cabot Corporation), in the Basic Materials sector, (Chemicals - Specialty industry), listed on NYSE.
Cabot Corporation operates as a specialty chemicals and performance materials company. It operates through three segments: Reinforcement Materials, Performance Chemicals, and Purification Solutions. The company offers reinforcing carbons used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites. It also provides specialty carbons used in inks, coatings, plastics, adhesives, toners, batteries, and displays applications; masterbatch and conductive compound products for use in automotive, industrial, packaging, infrastructure, agriculture, consumer products, and electronics industries; inkjet colorants used in the inkjet printing applications; fumed silica used in adhesives, sealants, cosmetics, batteries, inks, toners, silicone elastomers, coatings, polishing slurries, and pharmaceuticals; fumed alumina used in various products, including inkjet media, lighting, coatings, cosmetics, and polishing slurries; and aerogel, a hydrophobic, silica-based particle for use in various thermal insulation and specialty chemical applications. In addition, the company offers activated carbon products used for the purification of water, air, food and beverages, pharmaceuticals, and other liquids and gases; and activated carbon solutions for activated carbon injection in coal-fired utilities, mobile water filter units, and carbon reactivation services. The company sells its products through distributors and sales representatives in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.
CBT (Cabot Corporation) trades in the Basic Materials sector, specifically Chemicals - Specialty, with a market capitalization of approximately $4.28B, a trailing P/E of 15.13, a beta of 0.78 versus the broader market, a 52-week range of 58.33-86.43, average daily share volume of 401K, a public-listing history dating back to 1980, approximately 4K full-time employees. These structural characteristics shape how CBT stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.78 places CBT roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline. CBT pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.
What is a straddle on CBT?
A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration.
Current CBT snapshot
As of May 15, 2026, spot at $81.09, ATM IV 29.40%, IV rank 3.33%, expected move 8.43%. The straddle on CBT below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this straddle structure on CBT specifically: CBT IV at 29.40% is on the cheap side of its 1-year range, which favors premium-buying structures like a CBT straddle, with a market-implied 1-standard-deviation move of approximately 8.43% (roughly $6.83 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated CBT expiries trade a higher absolute premium for lower per-day decay. Position sizing on CBT should anchor to the underlying notional of $81.09 per share and to the trader's directional view on CBT stock.
CBT straddle setup
The CBT straddle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With CBT near $81.09, the first option leg uses a $81.09 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed CBT chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 CBT shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $81.09 | N/A |
| Buy 1 | Put | $81.09 | N/A |
CBT straddle risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit.
CBT straddle payoff curve
Modeled P&L at expiration across a range of underlying prices for the straddle on CBT. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use straddle on CBT
Straddles on CBT are pure-volatility plays that profit from large moves in either direction; traders typically buy CBT straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
CBT thesis for this straddle
The market-implied 1-standard-deviation range for CBT extends from approximately $74.26 on the downside to $87.92 on the upside. A CBT long straddle is a pure-volatility play: it profits when the underlying moves far enough from the strike in either direction to overcome the combined call plus put debit, regardless of direction. Current CBT IV rank near 3.33% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on CBT at 29.40%. As a Basic Materials name, CBT options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to CBT-specific events.
CBT straddle positions are structurally neutral / high-volatility (long premium); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. CBT positions also carry Basic Materials sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move CBT alongside the broader basket even when CBT-specific fundamentals are unchanged. Always rebuild the position from current CBT chain quotes before placing a trade.
Frequently asked questions
- What is a straddle on CBT?
- A straddle on CBT is the straddle strategy applied to CBT (stock). The strategy is structurally neutral / high-volatility (long premium): A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration. With CBT stock trading near $81.09, the strikes shown on this page are snapped to the nearest listed CBT chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are CBT straddle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit. For the CBT straddle priced from the end-of-day chain at a 30-day expiry (ATM IV 29.40%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a CBT straddle?
- The breakeven for the CBT straddle priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current CBT market-implied 1-standard-deviation expected move is approximately 8.43%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a straddle on CBT?
- Straddles on CBT are pure-volatility plays that profit from large moves in either direction; traders typically buy CBT straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
- How does current CBT implied volatility affect this straddle?
- CBT ATM IV is at 29.40% with IV rank near 3.33%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.